As a secondary aim, can I propose to measure treatment costs but not compare them? Or should I refrain from this area entirely, except for patient costs?

Please note that this funding program does not support applications to conduct cost-effectiveness analysis, although out-of-pocket costs for patients are appropriate to measure. For more information, please see the FAQ about cost effectiveness.